Harry Erba
Academic History
Harry Erba, MD, PhD, earned both his medical degree and PhD at Stanford University, Stanford, CA. He then completed his residency and a research/clinical fellowship in medicine at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
Dr Erba serves as the Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies at the Duke Cancer Institute, Durham, NC, and is a Professor of Medicine at the Duke University School of Medicine, Durham, NC.
Speaking on novel agents for the treatment of acute myeloid leukemia
As the Chair of the SWOG Leukemia Committee, Dr Erba participates in the clinical development of novel therapies for myeloid malignancies on a global scale. He has been the Principal Investigator in trials investigating small molecular inhibitors, antibody-drug conjugates, and cytotoxic chemotherapy. He provides updates on ongoing trials, predominantly investigating agents for the treatment of patients with acute myeloid leukemia (AML).
